ProMIS Neurosciences Inc. - Common Shares (PMN) earnings
PMN earnings moved a median of -2.35% by the close. Quarterly and annual PMN reports and results, each read against the price at its own news timestamp. Back to the PMN overview →
20 measured PMN earnings events.
Where these PMN earnings landedvs 20 measured PMN earnings reactions
| Middle 50% of PMN earnings reactions | -4.44% to +0.70% |
|---|---|
| Median reaction (to close) | -2.35% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 PMN earnings events with a measured close landed between -4.44% and +0.70%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ProMIS Neurosciences For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.75% | |
| ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights | Press release | +0.00% | -2.75% | |
| ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 | Press release | +0.00% | -5.24% | |
| Form 10-Q ProMIS Neurosciences For: Mar 31 | SEC filing · Form 10-Q | — | -2.33% | |
| Form 10-K ProMIS Neurosciences For: Dec 31 | SEC filing · Form 10-K | — | -4.18% | |
| Form 10-Q ProMIS Neurosciences For: Sep 30 | SEC filing · Form 10-Q | +1.19% | +1.38% | |
| ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights | Press release | +1.19% | +1.38% | |
| Form 10-Q ProMIS Neurosciences For: Jun 30 | SEC filing · Form 10-Q | +7.04% | +2.64% | |
| Form 10-Q ProMIS Neurosciences For: Mar 31 | SEC filing · Form 10-Q | -6.78% | -15.09% | |
| ProMIS Neurosciences Announces First Quarter 2025 Financial Results | Press release | -6.78% | -15.09% | |
| Form 10-K ProMIS Neurosciences For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.64% | |
| Form 10-Q ProMIS Neurosciences For: Sep 30 | SEC filing · Form 10-Q | — | -0.55% | |
| ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights | Press release | — | -0.55% | |
| Form 10-Q ProMIS Neurosciences For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.38% | |
| ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent Highlights | Press release | +0.00% | -2.38% | |
| Form 10-Q ProMIS Neurosciences For: Mar 31 | SEC filing · Form 10-Q | -0.51% | -7.69% | |
| ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights | Press release | -0.51% | -7.69% | |
| Form 10-K ProMIS Neurosciences For: Dec 31 | SEC filing · Form 10-K | — | +10.15% | |
| Form 10-Q ProMIS Neurosciences For: Sep 30 | SEC filing · Form 10-Q | -0.70% | +0.70% | |
| ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlights | Press release | -0.70% | +0.70% |
Keep exploring
More PMN: analyst actions → · SEC filings → · PMN overview →